Skip to main content

Table 3 Recurrence or metastases after treatment

From: Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study

Recurrence or metastasis CHIP group (n = 22) IV group (n = 21) P value
Total 14 19 0.037
Remnant gastric metastasis 5 5 0.933
Retroperitoneal lymph node metastasis 6 7 0.665
Hepatic metastasis 3 6 0.229
Peritoneal metastasis 1 7 0.021
Seroperitoneum 1 4 0.185
  1. CHIP chemotherapeutic hyperthermic intraperitoneal perfusion; IV chemotherapy alone